{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T12:49:43Z","timestamp":1779281383783,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.cll.2023.04.007","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T18:46:31Z","timestamp":1685645191000},"page":"411-426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical Flow Cytometry Analysis in the Setting of Chronic Myeloid Neoplasms and Clonal Hematopoiesis"],"prefix":"10.1016","volume":"43","author":[{"given":"Siba","family":"El Hussein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanam","family":"Loghavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cll.2023.04.007_bib1","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1038\/leu.2012.30","article-title":"Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group","volume":"26","author":"Westers","year":"2012","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.cll.2023.04.007_bib2","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/cyto.b.21965","article-title":"Diagnostic significance of flow cytometry scales in diagnostics of myelodysplastic syndromes","volume":"100","author":"Davydova","year":"2021","journal-title":"Cytometry B Clin Cytometry"},{"key":"10.1016\/j.cll.2023.04.007_bib3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.leukres.2007.06.012","article-title":"Flow cytometric analysis of myelomonocytic cells by a pattern recognition approach is sensitive and specific in diagnosing myelodysplastic syndrome and related marrow diseases: emphasis on a global evaluation and recognition of diagnostic pitfalls","volume":"32","author":"Stachurski","year":"2008","journal-title":"Leuk Res"},{"key":"10.1016\/j.cll.2023.04.007_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.leukres.2007.04.020","article-title":"Flow cytometry in myelodysplastic syndromes: report from a working conference","volume":"32","author":"Loken","year":"2008","journal-title":"Leuk Res"},{"key":"10.1016\/j.cll.2023.04.007_bib5","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3324\/haematol.2009.005801","article-title":"Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes","volume":"94","author":"van de Loosdrecht","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.cll.2023.04.007_bib6","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1182\/blood-2005-12-4916","article-title":"Diagnostic application of flow cytometric characteristics of CD34+ cells in low-grade myelodysplastic syndromes","volume":"108","author":"Ogata","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cll.2023.04.007_bib7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/cyto.b.21830","article-title":"Low-grade myelodysplastic syndromes with preserved CD34+ B-cell precursors (CD34+ hematogones)","volume":"98","author":"Chen","year":"2020","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.cll.2023.04.007_bib8","first-page":"1","article-title":"Immunophenotypic differentiation patterns of normal hematopoiesis in human bone marrow: reference patterns for age-related changes and disease-induced shifts","volume":"60","author":"van Lochem","year":"2004","journal-title":"Cytometry B Clin Cytometry"},{"key":"10.1016\/j.cll.2023.04.007_bib9","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.leukres.2009.01.012","article-title":"The utility of flow cytometric immunophenotyping in cytopenic patients with a non-diagnostic bone marrow: a prospective study","volume":"33","author":"Truong","year":"2009","journal-title":"Leuk Res"},{"key":"10.1016\/j.cll.2023.04.007_bib10","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1038\/leu.2013.178","article-title":"Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes","volume":"27","author":"Mathis","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.cll.2023.04.007_bib11","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3324\/haematol.2016.147843","article-title":"Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromes","volume":"102","author":"Cremers","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.cll.2023.04.007_bib12","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3324\/haematol.2016.147835","article-title":"Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group","volume":"102","author":"Westers","year":"2017","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.cll.2023.04.007_bib13","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/cyto.b.21975","article-title":"Exploring dyserythropoiesis in patients with myelodysplastic syndrome by imaging flow cytometry and machine-learning assisted morphometrics","volume":"100","author":"Rosenberg","year":"2021","journal-title":"Cytometry B Clin Cytometry"},{"key":"10.1016\/j.cll.2023.04.007_bib14","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/cyto.b.22095","article-title":"Flow cytometry immunophenotypic features of pure erythroid leukemia and the distinction from reactive erythroid precursors","volume":"102","author":"Fang","year":"2022","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.cll.2023.04.007_bib15","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3324\/haematol.2009.008532","article-title":"Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study","volume":"94","author":"Ogata","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.cll.2023.04.007_bib16","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.leukres.2011.02.016","article-title":"Flow cytometric scoring system as a diagnostic and prognostic tool in myelodysplastic syndromes","volume":"35","author":"Chu","year":"2011","journal-title":"Leuk Res"},{"key":"10.1016\/j.cll.2023.04.007_bib17","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1182\/blood-2002-09-2768","article-title":"Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation","volume":"102","author":"Wells","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cll.2023.04.007_bib18","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1038\/leu.2014.191","article-title":"Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes-proposal from the International\/European LeukemiaNet Working Group for Flow Cytometry in MDS","volume":"28","author":"Porwit","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.cll.2023.04.007_bib19","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1093\/ajcp\/aqz196","article-title":"CD177 enhances the detection of myelodysplastic syndrome by flow cytometry","volume":"153","author":"Alayed","year":"2020","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cll.2023.04.007_bib20","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3324\/haematol.2011.048421","article-title":"Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study","volume":"97","author":"Della Porta","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.cll.2023.04.007_bib21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/ajcp\/aqab116","article-title":"Flow cytometric findings in clonal cytopenia of undetermined significance","volume":"157","author":"Nirmalanantham","year":"2022","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cll.2023.04.007_bib22","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the world health organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.cll.2023.04.007_bib23","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/cytob.21215","article-title":"Flow cytometry immunophenotypic analysis of Philadelphia-negative myeloproliferative neoplasms: correlation with histopathologic features","volume":"88","author":"Ouyang","year":"2015","journal-title":"Cytometry B Clin Cytometry"},{"key":"10.1016\/j.cll.2023.04.007_bib24","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.3390\/diagnostics12071752","article-title":"When ring sideroblasts on bone marrow smears are inconsistent with the diagnosis of myelodysplastic neoplasms","volume":"12","author":"Girard","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.cll.2023.04.007_bib25","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2017"},{"issue":"3","key":"10.1016\/j.cll.2023.04.007_bib26","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/jha2.525","article-title":"Blastic plasmacytoid dendritic cell neoplasm (BPDCN) arising in the setting of polycythemia vera (PV): An illustration of the emerging role of flow cytometry analysis in monitoring progression of myeloproliferative neoplasms","volume":"3","author":"El Hussein","year":"2022","journal-title":"EJHaem"},{"key":"10.1016\/j.cll.2023.04.007_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-230332","article-title":"Blastic plasmacytoid dendritic cell neoplasm in the background of myeloproliferative disorder and chronic lymphocytic leukaemia","volume":"12","author":"Khan","year":"2019","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.cll.2023.04.007_bib28","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.3324\/haematol.2018.203018","article-title":"Loss of plasmacytoid dendritic cell differentiation is highly predictive for post-induction measurable residual disease and inferior outcomes in acute myeloid leukemia","volume":"104","author":"Xiao","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.cll.2023.04.007_bib29","doi-asserted-by":"crossref","first-page":"e685","DOI":"10.1097\/HS9.0000000000000685","article-title":"Reduced plasmacytoid dendritic cell output is associated with high risk in low-grade myelodysplastic syndrome","volume":"6","author":"Chan","year":"2022","journal-title":"Hemasphere"},{"key":"10.1016\/j.cll.2023.04.007_bib30","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/s41375-022-01538-9","article-title":"Bone marrow clonal hematopoiesis is highly prevalent in blastic plasmacytoid dendritic cell neoplasm and frequently sharing a clonal origin in elderly patients","volume":"36","author":"Khanlari","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.cll.2023.04.007_bib31","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/cyto.b.21842","article-title":"The diagnostic and prognostic role of flow cytometry in idiopathic and clonal cytopenia of undetermined significance (ICUS\/CCUS): a single-center analysis of 79 patients","volume":"98","author":"Dimopoulos","year":"2020","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.cll.2023.04.007_bib32","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/ijlh.13840","article-title":"Morphologic, immunophenotypic, and molecular genetic comparison study in patients with clonal cytopenia of undetermined significance, myelodysplastic syndrome, and acute myeloid leukemia with myelodysplasia-related changes: a single institution experience","volume":"44","author":"Gao","year":"2022","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.cll.2023.04.007_bib33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.cll.2023.04.007_bib34","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1182\/blood-2017-01-763425","article-title":"Clinical significance of somatic mutation in unexplained blood cytopenia","volume":"129","author":"Malcovati","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.cll.2023.04.007_bib35","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/ajh.25592","article-title":"The diagnostic utility of targeted gene panel sequencing in discriminating etiologies of cytopenia","volume":"94","author":"Zheng","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cll.2023.04.007_bib36","first-page":"1599","article-title":"Clonal hematopoiesis and risk for hematologic malignancy","volume":"136","author":"Warren","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.cll.2023.04.007_bib37","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1182\/blood-2015-08-663237","article-title":"Targeted sequencing identifies patients with preclinical MDS at high risk of disease progression","volume":"126","author":"Cargo","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.cll.2023.04.007_bib38","doi-asserted-by":"crossref","first-page":"5690","DOI":"10.3390\/cancers14225690","article-title":"The impact of clonal hierarchy and heterogeneity on phenotypic manifestations of myelodysplastic neoplasms","volume":"14","author":"El Hussein","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.cll.2023.04.007_bib39","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/ajh.23988","article-title":"The clinical significance of negative flow cytometry immunophenotypic results in a morphologically scored positive bone marrow in patients following treatment for acute myeloid leukemia","volume":"90","author":"Ouyang","year":"2015","journal-title":"Am J Hematol"},{"issue":"12","key":"10.1016\/j.cll.2023.04.007_bib40","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 ELN recommendations from an international expert panel","volume":"140","author":"Dohner","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.cll.2023.04.007_bib41","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1182\/blood-2017-09-801498","article-title":"Minimal\/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party","volume":"131","author":"Schuurhuis","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.cll.2023.04.007_bib42","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.beha.2018.09.013","article-title":"Is it time to routinely incorporate MRD into practice?","volume":"31","author":"Ravandi","year":"2018","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.cll.2023.04.007_bib43","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/bjh.17347","article-title":"Flow cytometric immunophenotypic alterations of persistent clonal haematopoiesis in remission bone marrows of patients with NPM1-mutated acute myeloid leukaemia","volume":"192","author":"Loghavi","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cll.2023.04.007_bib44","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1182\/blood.2019004770","article-title":"Clonal hematopoiesis and measurable residual disease assessment in acute myeloid leukemia","volume":"135","author":"Hasserjian","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.cll.2023.04.007_bib45","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1200\/JCO.2016.67.1875","article-title":"Postinduction minimal residual disease predicts outcome and benefit from allogeneic stem cell transplantation in acute myeloid leukemia with NPM1 mutation: a study by the acute leukemia French association group","volume":"35","author":"Balsat","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cll.2023.04.007_bib46","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1182\/blood.2020010483","article-title":"Clonal dynamics and clinical implications of postremission clonal hematopoiesis in acute myeloid leukemia","volume":"138","author":"Tanaka","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.cll.2023.04.007_bib47","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1200\/JCO.19.03011","article-title":"Impact of conditioning intensity of allogeneic transplantation for acute myeloid leukemia with genomic evidence of residual disease","volume":"38","author":"Hourigan","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cll.2023.04.007_bib48","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1182\/blood-2002-01-0222","article-title":"Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome","volume":"100","author":"Ogata","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cll.2023.04.007_bib49","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.leukres.2012.05.001","article-title":"Multi-color CD34(+) progenitor-focused flow cytometric assay in evaluation of myelodysplastic syndromes in patients with post cancer therapy cytopenia","volume":"36","author":"Tang","year":"2012","journal-title":"Leuk Res"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271223000458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271223000458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:09:04Z","timestamp":1715594944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271223000458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0272271223000458"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2023.04.007","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Flow Cytometry Analysis in the Setting of Chronic Myeloid Neoplasms and Clonal Hematopoiesis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cll.2023.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}